These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31301412)

  • 21. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Levivier M; Przedborski S; Bencsics C; Kang UJ
    J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; AlAseeri AA; Alruwaili M; Saad HM; Batiha GE
    J Cell Mol Med; 2024 May; 28(10):e18368. PubMed ID: 38752280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat.
    Groves DA; Bowman EM; Brown VJ
    Neurosci Lett; 2005 May; 379(3):174-9. PubMed ID: 15843058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vagus nerve stimulation parameters evoke differential neuronal responses in the locus coeruleus.
    Farrand A; Jacquemet V; Verner R; Owens M; Beaumont E
    Physiol Rep; 2023 Mar; 11(5):e15633. PubMed ID: 36905173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.
    Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration.
    Fischer DL; Kemp CJ; Cole-Strauss A; Polinski NK; Paumier KL; Lipton JW; Steece-Collier K; Collier TJ; Buhlinger DJ; Sortwell CE
    J Neurosci; 2017 Jul; 37(28):6786-6796. PubMed ID: 28607168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat vagus nerve stimulation model of seizure suppression: nNOS and ΔFos B changes in the brainstem.
    Rijkers K; Majoie HJ; Aalbers MW; Philippens M; Doenni VM; Vles JS; Steinbusch HM; Moers-Hornikx VM; Hopkins DA; Hoogland G
    J Chem Neuroanat; 2012 Dec; 46(1-2):1-9. PubMed ID: 23022956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.
    Real CC; Ferreira AF; Chaves-Kirsten GP; Torrão AS; Pires RS; Britto LR
    Neuroscience; 2013 May; 237():118-29. PubMed ID: 23396085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson's disease.
    Tuon T; Valvassori SS; Dal Pont GC; Paganini CS; Pozzi BG; Luciano TF; Souza PS; Quevedo J; Souza CT; Pinho RA
    Brain Res Bull; 2014 Sep; 108():106-12. PubMed ID: 25264157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DRD1 signaling modulates TrkB turnover and BDNF sensitivity in direct pathway striatal medium spiny neurons.
    Andreska T; Lüningschrör P; Wolf D; McFleder RL; Ayon-Olivas M; Rattka M; Drechsler C; Perschin V; Blum R; Aufmkolk S; Granado N; Moratalla R; Sauer M; Monoranu C; Volkmann J; Ip CW; Stigloher C; Sendtner M
    Cell Rep; 2023 Jun; 42(6):112575. PubMed ID: 37252844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Administration of Right Vagus Nerve Stimulation Activates Midbrain Dopaminergic Nuclei.
    Brougher J; Aziz U; Adari N; Chaturvedi M; Jules A; Shah I; Syed S; Thorn CA
    Front Neurosci; 2021; 15():782786. PubMed ID: 34975384
    [No Abstract]   [Full Text] [Related]  

  • 39. Astrocyte truncated tropomyosin receptor kinase B mediates brain-derived neurotrophic factor anti-apoptotic effect leading to neuroprotection.
    Saba J; Turati J; Ramírez D; Carniglia L; Durand D; Lasaga M; Caruso C
    J Neurochem; 2018 Sep; 146(6):686-702. PubMed ID: 29851427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra.
    Knott C; Stern G; Kingsbury A; Welcher AA; Wilkin GP
    Parkinsonism Relat Disord; 2002 Jun; 8(5):329-41. PubMed ID: 15177062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.